Events

Black Maternal and Infant Health SymposiumApr 14, 2025 from 08:30 AM to 04:30 PM— Clinical Translational Research Building 505 South Hancock St.,
The symposium unites healthcare providers, advocacy groups, social workers, and mental health professionals to address Black maternal and infant health disparities. The presentations and conversation will tackle implicit bias, improve communication, and implement best practices to prevent complications and reduce mortality rates in the Black community. It is a great time to learn about innovative programs, network, and advocate for policy changes and health equity.
University of Louisville Spring Dermatology Meeting 2025May 16, 2025 from 12:00 PM to 05:45 PM— 3810 Springhurst Blvd., Louisville, Kentucky, 40241,
​This year the focus of our course is on Complex Medical Dermatology. The meeting will begin with patient viewing focusing on patients with skin manifestations of systemic disease [some of the presentations will likely be posters when the live patients are not able to attend in person]. After a short break, we will begin with presentations by our residents of cases of the year. Following the resident presentations, we will discuss the patients who were presented. Our Visiting Professor will be asked to comment on each case as well. The case discussion will be followed by a lecture delivered by our visiting professor, Kanade Shinkai, MD, PhD Professor of Dermatology, University of California San Francisco.
2025 Neuro-Oncology Symposium: High-Grade Gliomas and GlioblastomasJun 28, 2025 from 07:30 AM to 01:15 PM— Kentucky Science Center 727 W Main Street, Louisville, KY 40202,
Each year, around 300,000 people around the world are diagnosed with glioblastoma, which is a type of high-grade gliomas. High-Grade Gliomas are an aggressive type of cancer found in the brain or spine. They are fast-growing and can spread quickly, which makes them harder to treat. Research shows there has not been any significant breakthroughs in treatment outcomes since the early 2000’s. There are currently several active clinical trials to help patients with these tumors. During this course, we will take a look at some of those promising trials, as well as advances in pathological/genetic testing, and other advancements in treatment options to treat high-grade gliomas and glioblastomas.